Designed for corporate purchasing managers, technical directors, and operations leaders who demand consistent batch quality and on‑time supply for peptide‑based projects.
In 2025, 45% of pharmaceutical R&D teams reported project delays caused by peptide instability and supply chain bottlenecks. If you’re still wrestling with the following issues, you’re not alone:
These pain points translate directly into 30‑40% higher R&D costs and missed market windows. Imagine the impact on your ROI when each trial repeats because of peptide inconsistency.
Discover how our DPP‑IV resistant GRF peptide eliminates these risks.
Our patented peptide design replaces the native alanine at position 2 with a D‑isoleucine, creating a molecule that is 10‑fold more resistant to DPP‑IV cleavage while preserving full biological activity. The result? A stable, high‑purity product that arrives on your bench ready to deliver consistent data.
| Parameter | Value | Unit |
|---|---|---|
| Peptide Sequence | [D‑Ile^2]‑GHRH‑(1‑29)‑NH2 | |
| Molecular Weight | 3275.5 | Da |
| Purity (HPLC) | ≥ 98.5 | % |
| DPP‑IV Resistance | > 90 % retained activity after 2 h serum incubation | |
| Form | Lyophilized powder / Sterile solution | |
| Storage | -20 °C, desiccated |
Case 1 – Academic Hormone Research (USA)
A leading endocrinology lab reduced assay variability from 12% to 3% by switching to our DPP‑IV resistant GRF peptide, cutting total project time by 28 days.
Case 2 – Biotech Startup (Canada)
Leveraging our OEM capability, a biotech firm launched a Phase I trial within 6 weeks, a timeline 40% faster than industry averages.
Case 3 – Contract Manufacturing Organization (UK)
By sourcing bulk (> 2 kg) from our factory, the CMO saved US$ 15,000 per batch while maintaining GMP compliance.
Ready to experience these results?
C59H108N17O15S-molecular-formula-CAS-number CAS-34444-37-6-Sildenafil-Citrate Autophagy-Inducer Bovine-GRF-(1-44)-amide-supplier
DPP‑IV (dipeptidyl‑peptidase IV) rapidly cleaves native GRF‑(1‑29) at the second amino‑acid position, reducing its activity. Our peptide replaces this site with a D‑isoleucine, making it 10‑fold more stable in human serum, which translates into reliable experimental outcomes and lower dosing requirements.
Yes. We support orders from **100 mg** (research scale) up to **5 kg** (industrial scale). OEM/ODM formulations, including custom salts, lyophilization cycles, and packaging, are available upon request.

Standard terms are **T/T 30 % deposit, 70 % against B/L**. For qualified long‑term partners we can arrange **L/C at sight** or **net‑30 days** after the first shipment.
Express air freight from Zhengzhou to Los Angeles or New York is **7‑9 business days** after QC release. For larger volumes, sea freight is available with a 20‑day transit time plus customs clearance.
Every batch is accompanied by a detailed CoA covering HPLC purity, mass verification (LC‑MS), endotoxin level, and DPP‑IV resistance assay results.
Our technical service team provides **24 h email support**, a **dedicated application scientist**, and **free protocol optimization** for the first three orders.
Act within 7 days to secure your risk‑free trial. No hidden fees, money‑back guarantee if the peptide does not meet the stated specifications.
Or call us directly at +86 199 4383 0844 (WhatsApp available) for an instant quote.
Dr. Laura Mitchell, Research Lead, NeuroGen Labs
“The DPP‑IV resistant GRF peptide delivered consistent hormone release curves across three separate batches—something we never achieved before.”
James Patel, Procurement Manager, HealthTech Corp.
“Pricing was 30% lower than our previous supplier, and the 5‑day express delivery kept our project on schedule.”
Maria Gonzales, CEO, Peptide Innovations LLC
“Their OEM service let us launch a custom‑labeled peptide line in under a month—exceptional speed and quality control.”
Trusted by Global Leaders
“Switching to Global Technology’s DPP‑IV resistant GRF peptide cut our assay failure rate by 85% and saved us over $20k in reagent costs.”
– Dr. Emily Chen, Senior Scientist, BioPharma Inc.
“Their fast‑track logistics let us receive 5 kg of peptide within 8 days, enabling a rapid go‑no‑go decision for our clinical candidate.”
– Michael Rivera, Procurement Manager, MedTech Solutions
Certificates & Compliance